TrialPanorama/TrialPanorama-database huggingface dataset:
Study 21752880 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 19635616 — Surrogate Endpoint (SUR): Bone mineral density
Study 22707560 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8568002 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27010144 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27010144 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20199985 — Surrogate Endpoint (SUR): Bone mineral density
Study 12028504 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16777318 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 16777318 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 16777318 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 11985406 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31702469 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 24500238 — Surrogate Endpoint (SUR): Serum creatinine
Study 12140629 — Predictive Biomarker (PRD): GDA mRNA
Genes: GDA; KIAA1258
Study 2649197 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 20687931 — Surrogate Endpoint (SUR): Blood pressure
Study 1837713 — Surrogate Endpoint (SUR): Blood pressure
Study 6354904 — Monitoring Biomarker (MOI): HBV DNA
Study 28070602 — Predictive Biomarker (PRD): PCSK5 mRNA
Genes: PCSK5; PC5; PC6
Study 27115567 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 15867044 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 30025007 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study 30025007 — Predictive Biomarker (PRD): ODAM mRNA
Genes: ODAM; APIN
Study 30025007 — Predictive Biomarker (PRD): FDCSP mRNA
Genes: FDCSP; C4orf7; UNQ733/PRO1419
Study 24045403 — Surrogate Endpoint (SUR): Blood pressure
Study 9209645 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 9209645 — Predictive Biomarker (PRD): EEF1E1 mRNA
Genes: EEF1E1; AIMP3; P18
Study 9209645 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 3689626 — Surrogate Endpoint (SUR): Blood pressure
Study 20388917 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20388917 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 20388917 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 24418164 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 21701811 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 21701811 — Surrogate Endpoint (SUR): Blood pressure
Study 16019355 — Surrogate Endpoint (SUR): Bone mineral density
Study 16019355 — Surrogate Endpoint (SUR): Blood pressure
Study 23860695 — Surrogate Endpoint (SUR): Blood pressure
Study 18327066 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21537858 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 18264697 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 31241173 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 31241173 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 18019665 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study 18019665 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 15668481 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 15668481 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 10770450 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 8681493 — Surrogate Endpoint (SUR): Blood pressure
Study 1920817 — Surrogate Endpoint (SUR): Blood pressure
Study 25491391 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 7608809 — Surrogate Endpoint (SUR): Serum luteinizing hormone
Study 2122713 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22222299 — Surrogate Endpoint (SUR): Serum calcium
Study 7934188 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 28117141 — Predictive Biomarker (PRD): UCHL1 mRNA
Genes: UCHL1
Study 28117141 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 25967848 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 25967848 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25967848 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25967848 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25967848 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 11247890 — Surrogate Endpoint (SUR): Bone mineral density
Study 8314169 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30252723 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 30252723 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 20507378 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 20507378 — Surrogate Endpoint (SUR): Probing pocket depth
Study 12356338 — Surrogate Endpoint (SUR): Blood pressure
Study 31056705 — Surrogate Endpoint (SUR): Serum uric acid
Study 18343264 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study 8916480 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8916480 — Surrogate Endpoint (SUR): Blood pressure
Study 8916480 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8916480 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12843167 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12843167 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8635380 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 3867301 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 10097952 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26507685 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 1825332 — Surrogate Endpoint (SUR): Probing pocket depth
Study 20851820 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study 17609220 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 17609220 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 16469157 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 2425671 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 14597105 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 14597105 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 14597105 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 25348661 — Monitoring Biomarker (MOI): HBV DNA
Study 29791011 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 29791011 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study 29791011 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MRP2
Genes: ABCC2; DJS; cMRP
Study 29791011 — Predictive Biomarker (PRD): ABCC3 mRNA
Genes: ABCC3; CMOAT2; MLP2; MRP3
Study 29791011 — Predictive Biomarker (PRD): ABCC4 mRNA
Genes: ABCC4; MOATB; MRP4
Study 29791011 — Predictive Biomarker (PRD): ABCG2 mRNA
Genes: ABCG2; ABCP; BCRP; BCRP1; MXR
Study 29791011 — Predictive Biomarker (PRD): SLC19A1 mRNA
Genes: SLC19A1; FLOT1; RFC1
Study 29791011 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study 27068332 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27068332 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27068332 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 27068332 — Surrogate Endpoint (SUR): Blood pressure
Study 25196897 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 10439882 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31113841 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 31113841 — Predictive Biomarker (PRD): HSPA1B mRNA
Genes: HSPA1B; HSP72
Study 9933837 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 29479070 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 29479070 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 23098887 — Surrogate Endpoint (SUR): Blood pressure
Study 22087616 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31838377 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 31838377 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31838377 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25602128 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 18953265 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 30229370 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30229370 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 24732311 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 18630537 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 7554626 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 31388638 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study 23797498 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20945253 — Surrogate Endpoint (SUR): Blood pressure
Study 19145002 — Surrogate Endpoint (SUR): Blood pressure
Study 9052418 — Surrogate Endpoint (SUR): Bone mineral density
Study 27020594 — Safety Biomarker (SAF): IL-6 and IL-10
Study 28028649 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19030637 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 16098704 — Surrogate Endpoint (SUR): Blood pressure
Study 18219455 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 18219455 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 15681495 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 12952502 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 1826008 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 1826008 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 1826008 — Surrogate Endpoint (SUR): Serum sodium
Study 1826008 — Surrogate Endpoint (SUR): Blood pressure
Study 6640551 — Surrogate Endpoint (SUR): Serum creatinine
Study 22424116 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 18207457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18207457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18207457 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 18207457 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 18207457 — Safety Biomarker (SAF): IL-6 and IL-10
Study 15167461 — Surrogate Endpoint (SUR): Blood pressure
Study 9616507 — Surrogate Endpoint (SUR): Blood pressure
Study 8018402 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 895434 — Surrogate Endpoint (SUR): Blood pressure
Study 31190492 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18273622 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 18273622 — Predictive Biomarker (PRD): SLC22A3 mRNA
Genes: SLC22A3; EMTH; OCT3
Study 11106130 — Surrogate Endpoint (SUR): Blood pressure
Study 9082867 — Surrogate Endpoint (SUR): Blood pressure
Study 8522636 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8522636 — Surrogate Endpoint (SUR): Blood pressure
Study 31677033 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study 22108480 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 19778662 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19778662 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19778662 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 3352193 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 31279641 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 19196574 — Predictive Biomarker (PRD): RITA1 mRNA
Genes: RITA1; C12orf52; RITA; PSEC0043
Study 18188164 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18188164 — Surrogate Endpoint (SUR): Blood pressure
Study 9522671 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study 28209746 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 28209746 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 28209746 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 15579521 — Surrogate Endpoint (SUR): Serum creatinine
Study 8136093 — Surrogate Endpoint (SUR): Blood pressure
Study 20187772 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 20187772 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18028434 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 18028434 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 3095913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 23192920 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 31194785 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31194785 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 31194785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31194785 — Predictive Biomarker (PRD): IL7 mRNA
Genes: IL7
Study 31194785 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 31194785 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 31194785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28130379 — Surrogate Endpoint (SUR): Serum sodium
Study 28130379 — Surrogate Endpoint (SUR): Serum creatinine
Study 20858487 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 20858487 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 9322449 — Surrogate Endpoint (SUR): Blood pressure
Study 8384887 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 3529909 — Surrogate Endpoint (SUR): Blood pressure
Study 31167889 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 27632886 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study 27421242 — Surrogate Endpoint (SUR): Blood pressure
Study 16331103 — Surrogate Endpoint (SUR): Blood pressure
Study 12800457 — Surrogate Endpoint (SUR): Blood pressure
Study 1974503 — Surrogate Endpoint (SUR): Blood pressure
Study 24185285 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study 19589009 — Surrogate Endpoint (SUR): Bone mineral density
Study 15213060 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 7653793 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7653793 — Surrogate Endpoint (SUR): Blood pressure
Study 2744287 — Surrogate Endpoint (SUR): Blood pressure
Study 29316016 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 3910726 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 3910726 — Surrogate Endpoint (SUR): Blood pressure
Study 29078037 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 29078037 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20889939 — Surrogate Endpoint (SUR): Blood pressure
Study 7036710 — Surrogate Endpoint (SUR): Blood pressure
Study 24695896 — Surrogate Endpoint (SUR): Serum calcium
Study 24695896 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 1696846 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 21518010 — Surrogate Endpoint (SUR): Blood pressure
Study 24155139 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21700013 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21700013 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16818571 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16818571 — Surrogate Endpoint (SUR): Blood pressure
Study 16818571 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 6354937 — Surrogate Endpoint (SUR): Blood pressure
Study 24423921 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study 10196013 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 26901306 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 15636224 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 25494622 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 20047624 — Surrogate Endpoint (SUR): Blood pressure
Study 18821658 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7555166 — Predictive Biomarker (PRD): PRCP mRNA
Genes: PRCP; PCP
Study 30814669 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 30814669 — Predictive Biomarker (PRD): CDCA3 mRNA
Genes: CDCA3; C8; GRCC8; TOME1
Study 21370402 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 11446582 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 12791655 — Safety Biomarker (SAF): Glutathione S-transferase P
Genes: GSTP1; FAEES3; GST3
Study 1880234 — Surrogate Endpoint (SUR): Serum uric acid
Study 6974948 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 6974948 — Surrogate Endpoint (SUR): Blood pressure
Study 28445854 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FGA mRNA
Genes: FGA
Study 11713356 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 3318971 — Surrogate Endpoint (SUR): Forced vital capacity
Study 17251232 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 17251232 — Surrogate Endpoint (SUR): Forced vital capacity
Study 24415665 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 11679974 — Monitoring Biomarker (MOI): HBV DNA
Study 9234663 — Surrogate Endpoint (SUR): Blood pressure
Study 7900237 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31621254 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 11115443 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31452319 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 31452319 — Surrogate Endpoint (SUR): Serum creatinine
Study 19091796 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 17205963 — Predictive Biomarker (PRD): CNDP1 mRNA
Genes: CNDP1; CN1; CPGL2; UNQ1915/PRO4380
Study 11514072 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 28130659 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26440236 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 26440236 — Surrogate Endpoint (SUR): Serum creatinine
Study 21289249 — Surrogate Endpoint (SUR): Serum calcium
Study 15449756 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2197852 — Surrogate Endpoint (SUR): Plasma phenylalanine
Study 20626052 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 11168329 — Surrogate Endpoint (SUR): Blood pressure
Study 24074713 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 24074713 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 29575909 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29575909 — Predictive Biomarker (PRD): GSS mRNA
Genes: GSS
Study 20954761 — Predictive Biomarker (PRD): DRD4 mRNA
Genes: DRD4
Study 18239552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18239552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18239552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8561641 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 6221200 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 30059193 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 30558053 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 16213233 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 20378684 — Surrogate Endpoint (SUR): Blood pressure
Study 21974759 — Surrogate Endpoint (SUR): Blood pressure
Study 18199300 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 6146414 — Surrogate Endpoint (SUR): Blood pressure
Study 29377893 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 29377893 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 21440951 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 21440951 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 8364139 — Monitoring Biomarker (MOI): HBV DNA
Study 24621122 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD